Treatment & Outcomes of Diabetes Patients During the COVID-19 Pandemic

After nearly six months of coping with the COVID-19 pandemic, InCrowd wanted to understand how diabetes patients and providers are managing their diseases and maintaining their treatment paradigms amidst the various challenges that threaten patient safety and access to care.

We would like to thank our friends at Market Cube for their help in sourcing this important research.


  • Method:
    • Physicians: 8-Minute MicroSurvey via InCrowd
    • Patients: 2-Minute MicroSurvey via InCrowd and Market Cube
  • Crowds:
    • US Primary Care Physicians (PCPs) and Endocrinologists (Endos)
    • Diabetes Patients
  • Sample Size:
    • Physicians: 102 Total
      • PCPs: 51%
      • Endos: 49%
    • Patients: 102 Total
  • Fielding Period:
    • Physicians: August 4, 2020 (3 hours)
    • Patients: August 5-7, 2020 (48 hours)
  • Screening Criteria
    • Physicians currently treating at least 15 diabetes type 1 patients and 25 type 2 patients
    • Patients actively seeking treatment for diabetes type 1 or type 2

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Why Diversity Matters to Patients

Why Diversity Matters to Patients

How does a diverse patient audience feel about representation among their own physicians? Is the diversity outlook improving among healthcare professionals? Find out in our latest report from the 2023 Pharma Market Research Conference. We examined: Satisfaction with...

read more